Skip to main content

Laboratoires Fournier Licenses BioBase's Transcription Database

NEW YORK (GenomeWeb News) — French company Laboratoires Fournier will license BioBase’s TRANSFAC eukaryotic gene-regulation database, BioBase said today.
 
BioBase said the Dijon-based company will use the database to develop therapeutics for metabolic and cardiovascular diseases.
 
BioBase, headquartered in Wolfenbuttell, Germany, said the TRANSFAC database holds information on 8,700 transcription factors and is used to identify and analyze binding sites.
 
The company said the database, which it updates every three months, also visualizes, interprets, and predicts gene-regulatory networks.
 
Financial terms of the agreement were not released.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.